Inflammation and epilepsy: The foundations for a new therapeutic approach in epilepsy?

Epilepsy Currents

Volumn 12, Issue 1, 2012, Pages 8-12

  Walker, Lauren ^a   Sills, Graeme J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BICUCULLINE; CASPASE INHIBITOR; HIGH MOBILITY GROUP B1 PROTEIN; IFENPRODIL; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; KAINIC ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VX 765;

ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG RESEARCH; DRUG TARGETING; ENCEPHALITIS; EPILEPSY; EPILEPTOGENESIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; NEUROBIOLOGY; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84864305538     PISSN: 15357597     EISSN: 15357511     Source Type: Journal    
DOI: 10.5698/1535-7511-12.1.8     Document Type: Review

References (53)

1. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell 2010;140:918-934.
2. Vezzani A, French JA, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011;7:31-40.
3. Hart YM, Cortez M, Andermann F, Hwang P, Fish DR, Dulac O, Silver K, Fejerman N, Cross J, Sherwin A, Caraballo R. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): Effect of high-dose steroids or immunoglobulins in 19 patients. Neurology 1994;44:1030-1036.
4. Snead OC. How does ACTH work against infantile spasms? Bedside to bench. Ann Neurol 2001;49:288-289.
5. Maroso M, Balosso, Ravizza T, Liu J, Bianchi ME, Vezzani A. Interleukin- 1 type 1 receptor/Toll-like receptor signalling in epilepsy: The importance of IL-1beta and high-mobility group box 1. J Intern Med 2011;270:319-326.
6. Becher B, Prat A, Antel JP. Brain-immune connection: Immunoregulatory properties of CNS-resident cells. Glia 2000;29:293-304.
7. Vezzani A, Maroso M, Balosso S, Sanchez M-A, Bartfai T. IL-1 receptor/ Toll-like receptor signalling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 2011;25:1281-1289.
8. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2:734-744.
9. Aloisi F, Ria F, Adorini L. Regulation of T-cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes. Immunol Today 2000;21:141-147.
10. Stoll G, Jander S, Schroeter M. Cytokines in CNS disorders: Neurotoxicity versus neuroprotection. J Neural Transm Suppl 2000;59:81-89.
11. Wood PL. Microglia: Roles of microglia in chronic neurodegenerative diseases. In: Neuroinflammation: Mechanisms and Management. (Wood PL, ed.) Totowa: Humana Press, 2003:3-27.
12. Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008;22:797-803.
13. De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, De Luigi A, Garattini S, Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000;12:2623-2633.
14. Crespel A, Coubes P, Rousset MC, Brana C, Rougier A, Rondouin G, Bockaert J, Baldy-Moulinier M, Lerner-Natoli M. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res 2002;952:159-169.
15. Ravizza T, Boer K, Redeker S, Spliet WG, van Rijen PC, Troost D, Vezzani A, Aronica E. The Il-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 2006;24:128-143.
16. Boer K, Jansen F, Nellist M, Redeker S, van den Ouweland AM, Spliet WG, van Nieuwenhuizen O, Troost D, Crino PB, Aronica E. Inflammatory processes in cortical tubers, and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 2008;78:7-21.
17. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: Evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008;29:142-160.
18. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures. J Neurosci 1999;19:5054-5065.
19. Dubé C, Vezzani A, Behrens M, Bartfai T, Baram TZ. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol 2005;57:152-155.
20. Heida JG, Pittman QJ. Causal links between brain cytokines and experimental febrile convulsions in the rat. Epilepsia 2005;46:1906- 1913.
21. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, De Simoni MG, Sperk G, Andell-Jonsson S, Lundkvist J, Iverfeldt K, Bartfai T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 2000;97:11534-11539.
22. Auvin S, Shin D, Mazarati A, Sankar R. Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia 2010;51 (suppl):34-38.
23. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M. Interleukin- 1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003;23:8692-8700.
24. Balosso S, Maroso M, Sanchez-Alavez M, Ravizza T, Frasca A, Bartfai T, Vezzani A. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 2008;131:3256-3265.
25. Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 2000;7:153-159.
26. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A. CXCR4-activated astrocyte glutamate release via TNFalpha: Amplification by microglia triggers neurotoxicity. Nat Neurosci 2001;4:702-710.
27. Viviani B, Gardoni F, Marinovich M. Cytokines and neuronal ion channels in health and disease. Int Rev Neurobiol 2007;82:247-263.
28. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007;13:460-469.
29. Bianchi ME, Manfredi AA. Immunology: Dangers in and out. Science 2009;323:1683-1684.
30. Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer A, Rossetti C, Molteni M, Casalgrandi M, Manfredi A, Bianchi M, Vezzani A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nature Med 2010;16:413-420.
31. Riazi K, Galic MA, Pittman QJ. Contributions of peripheral inflammation to seizure susceptibility: Cytokines and brain excitability. Epilepsy Res 2010;89:34-42.
32. Cacheaux LP, Ivens S, David Y, Lakhter AJ, Bar-Klein G, Shapira M, Heinemann U, Friedman A, Kaufer D. Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci 2009;29:8927-8935.
33. Kulkarni SK, Dhir A. Cyclooxygenase in epilepsy: From perception to application. Drugs Today 2009;45:135-154.
34. Friedman A, Kaufer D, Heinemann U. Blood-brain barrier breakdowninducing astrocytic transformation: Novel targets for the prevention of epilepsy. Epilepsy Res 2009;85:142-149.
35. Cornford EM. Epilepsy and the blood brain barrier: Endothelial cell responses to seizures. Adv Neurol 1999;79:845-862.
36. Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L, Bach S, Angiari S, Benati D, Chakir A, Zanetti L, Schio F, Osculati A, Marzola P, Nicolato E, Homeister JW, Xia L, Lowe JB, McEver RP, Osculati F, Sbarbati A, Butcher EC, Constantin G. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 2008;14:1377-1383.
37. Kim JV, Kang SS, Dustin ML, McGavern DB. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 2009;457:193-195.
38. David Y, Cacheaux L, Ivens S, Lapilover E, Heinemann U, Kaufer D, Friedman A. Astrocytic dysfunction in epileptogenesis: Consequence of altered potassium and glutamate homeostasis? J Neurosci 2009;29:10588-10599.
39. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003;101:2652-2660.
40. Hreggvidsdottir HS, Ostberg T, Wähämaa H, Schierbeck H, Aveberger AC, Klevenvall L, Palmblad K, Ottosson L, Andersson U, Harris HE. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 2009;86:655- 662.
41. Friedman A, Dingledine R. Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia 2011;52(suppl):33-39.
42. Auvin S, Shin D, Mazarati A, Nakagawa J, Miyamoto J, Sankar R. Inflammation exacerbates seizure-induced injury in the immature brain. Epilepsia 2007;48(suppl):27-34.
43. Bouilleret V, Ridoux V, Depaulis A, Marescauz C, Nehlig A, Le Gal La Salle G. Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: Electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience 1999;89:717-729.
44. Yang H, Wang H, Czura CJ, Tracey KJ. HMGB1 as a cytokine and therapeutic target. J Endotoxin Res 2002;8:469-472.
45. Mazarati A, Maroso M, Iori V, Vezzani A, Carli M. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and receptor for advanced glycation end products. Exp Neurol 2011;232:143-148.
46. Costello DA, Watson MB, Cowley TR, Murphy N, Murphy Royal C, Garlanda C, Lynch MA. Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice. J Neurosci 2011;31:3871-3879.
47. Zurolo E, Iyer A, Maroso M, Carbonell C, Anink J, Ravizza T, Fluiter K, Spliet WGM, van Rijen P, Vezzani A, Aronica E. Activation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain 2011;134:1015-1032.
48. Andersson U, Rauvala H. Introduction: HMGB1 in inflammation and innate immunity. J Intern Med 2011;270:296-300.
49. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, Flavell RA. Altered cytokine export and apoptosis in mice deficient in interleukin- 1 beta converting enzyme. Science 1995;267:2000-2003.
50. Ravizza T, Lucas SM, Balosso S, Bernardino L, Ku G, Noe F, Malva J, Randle JC, Allan S, Vezzani A. Inactivation of caspase-1 in rodent brain: A novel anticonvulsant strategy. Epilepsia 2006;47:1160-1168.
51. Maroso M, Baloso S, Ravizza T, Iori V, Wright CI, French J, Vezzani A. Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 2011;8:304-315.
52. Randle JCR, Harding MW, Ku G, Schönharting M, Kurrle R. ICE/Caspase- 1 inhibitors as novel anti-inflammatory drugs. Exp Opin Invest Drugs 2001;10:1207-1209.
53. Vertex Pharmaceuticals Incorporated. Study of VX-765 in subjects with treatment-resistant partial epilepsy. ClinicalTrials.gov database.http://clinicaltrials.gov/ct2/show/NCT01048255. Accessed October 18, 2011.